Sutro Biopharma (STRO) Other Non-Current Assets (2016 - 2025)

Sutro Biopharma has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $858000.0 for Q4 2025.

• Other Non-Current Assets for Q4 2025 came in at $858000.0, down 4.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $858000.0 (down 4.67% YoY), and the FY2025 annual result was $858000.0, down 4.67% from the prior year.
• Other Non-Current Assets came in at $858000.0 for Q4 2025 at Sutro Biopharma, roughly flat from $858000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.6 million in Q4 2023 to a low of $857000.0 in Q1 2024.
• The 5-year median for Other Non-Current Assets is $872000.0 (2021), against an average of $1.0 million.
• Across the five-year window, Other Non-Current Assets jumped 5713.33% in 2021 and plunged 74.77% in 2024, its largest moves.
• Sutro Biopharma's Other Non-Current Assets stood at $872000.0 in 2021, then changed by 0.0% to $872000.0 in 2022, then soared by 309.06% to $3.6 million in 2023, then slumped by 74.77% to $900000.0 in 2024, then declined by 4.67% to $858000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $858000.0 (Q4 2025), $858000.0 (Q2 2025), and $858000.0 (Q1 2025), per Business Quant data.